Australia's most trusted
source of pharma news
Wednesday, 04 June 2025
Posted 19 June 2023 AM
In just six months new Ipsen General Manager ANZ Julien Dagher has undertaken a bold company transformation and built a dynamic leadership team including four new faces.
The shake-up is anchored around a burgeoning portfolio with five to seven new product launches expected in the next two years as the company doubles down on its focus on oncology, rare disease and neuroscience.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.